Reticular is an AI based Biotechnology Research firm that discover bilogical drugs with limited data.
Reticular has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2024.
Reticular's investors include Y Combinator.
Reticular is headquartered in San Francisco, United States.
Reticular is an AI based Biotechnology Research firm that discover bilogical drugs with limited data.
Reticular is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reticular — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/reticular. Accessed August 1, 2026.
VCBacked. (2024). Reticular — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/reticular
{{cite web |title=Reticular — Funding & Investors |url=https://www.vcbacked.co/company/reticular |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated